Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ruffion

Showing results (151-160 of 174) with videos related to

Pageof 18
Sort By:
Journal of Visceral Surgery|April 26, 2020
Reform of the 3rd cycle in surgery trainingO Farges, C Bertolus, H Thomazeau, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]F Bottet, B Peyronnet, X Game, et al.
Annales De Readaptation Et De Medecine Physique : Revue Scientifique De La Societe Francaise De Reeducation Fonctionnelle De Readaptation Et De Medecine Physique|June 3, 2008
[Patient follow-up after botulinum toxin intradetrusor injection. Proposal for management in neurogenic patients]M de Sèze, A Ruffion, F Haab, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 27, 2009
[Criteria and best clinical practice guidelines for first intradetrusor injection of botulinum toxin type A to treat neurogenic detrusor overactivity]B Perrouin-Verbe, A Ruffion, X Gamé, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 7, 2022
[DNA repair gene alterations testing in prostate cancer : A practical update by the prostate cancer committee of the french association of urology]G Ploussard, J-B Beauval, R Mathieu, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|September 13, 2014
Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management: Translation of French recommendationsJ-F Hermieu, P Ballanger, G Amarenco, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 10, 2015
[Idiopathic overactive bladder and BOTOX(®): Literature review]X Gamé, G Karsenty, A Ruffion, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|September 17, 2013
[Guidelines from the Infectious Disease Committee of the French Association of Urology and The Neuro-Urology Committee of the AFU: antibiotic prophylaxis for sacral neuromodulation]J D Doublet, A Sotto, L Escaravage, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 30, 2013
[Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management]J-F Hermieu, P Ballanger, G Amarenco, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|August 4, 2014
[Intra-detrusor injection of botulinum toxin for female refractory idiopathic overactive bladder syndrome]X Deffieux, B Fatton, P Denys, et al.
Pageof 18

Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
Journal of Visceral Surgery|April 26, 2020
Reform of the 3rd cycle in surgery trainingO Farges, C Bertolus, H Thomazeau, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]F Bottet, B Peyronnet, X Game, et al.
Annales De Readaptation Et De Medecine Physique : Revue Scientifique De La Societe Francaise De Reeducation Fonctionnelle De Readaptation Et De Medecine Physique|June 3, 2008
[Patient follow-up after botulinum toxin intradetrusor injection. Proposal for management in neurogenic patients]M de Sèze, A Ruffion, F Haab, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 27, 2009
[Criteria and best clinical practice guidelines for first intradetrusor injection of botulinum toxin type A to treat neurogenic detrusor overactivity]B Perrouin-Verbe, A Ruffion, X Gamé, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 7, 2022
[DNA repair gene alterations testing in prostate cancer : A practical update by the prostate cancer committee of the french association of urology]G Ploussard, J-B Beauval, R Mathieu, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|September 13, 2014
Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management: Translation of French recommendationsJ-F Hermieu, P Ballanger, G Amarenco, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 10, 2015
[Idiopathic overactive bladder and BOTOX(®): Literature review]X Gamé, G Karsenty, A Ruffion, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|September 17, 2013
[Guidelines from the Infectious Disease Committee of the French Association of Urology and The Neuro-Urology Committee of the AFU: antibiotic prophylaxis for sacral neuromodulation]J D Doublet, A Sotto, L Escaravage, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 30, 2013
[Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management]J-F Hermieu, P Ballanger, G Amarenco, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|August 4, 2014
[Intra-detrusor injection of botulinum toxin for female refractory idiopathic overactive bladder syndrome]X Deffieux, B Fatton, P Denys, et al.
Pageof 18